Comparison of partial and superficial or total parotidectomies for superficial T1-2 primary parotid cancers

IF 2.9 3区 医学 Q1 OTORHINOLARYNGOLOGY Clinical and Experimental Otorhinolaryngology Pub Date : 2023-12-26 DOI:10.21053/ceo.2023.00014
Seung Hoon Han, Jihae Lee, Jeong Wook Kang, Heejin Kim, Dong Jin Lee, Jin Hwan Kim, Il Seok Park
{"title":"Comparison of partial and superficial or total parotidectomies for superficial T1-2 primary parotid cancers","authors":"Seung Hoon Han, Jihae Lee, Jeong Wook Kang, Heejin Kim, Dong Jin Lee, Jin Hwan Kim, Il Seok Park","doi":"10.21053/ceo.2023.00014","DOIUrl":null,"url":null,"abstract":"Objective: This study aimed to compare the oncological outcomes of partial and superficial or total parotidectomies for superficial T1 or T2 primary parotid cancers and investigate their prognostic factors and recurrence patterns. Methods: The medical records of 77 patients with T1–2 primary parotid malignancies between May 2003 and March 2022 were retrospectively reviewed. Univariate and multivariate analyses were performed to evaluate the prognostic factors associated with overall survival, disease-free survival, and local and distant recurrences. Results: The average follow-up duration was 70.2 months (range,12–202 months). The 5-year overall and disease-free survival rates were 88.7% and 77.1%, respectively. Twenty-two patients underwent partial parotidectomy, and 55 underwent superficial or total parotidectomy. There were no significant differences in the disease recurrence ( p =0.320) and mortality rates ( p =0.884) of the partial and superficial or total parotidectomy groups. The mean duration of surgery was shorter and the overall complication rates were significantly lower for the partial group than for the superficial or total parotidectomy group ( p =0.049). Sixteen cases of recurrence occurred during the study period (20.8%). Univariate analyses showed that high-grade tumors ( p =0.006), lymphovascular invasion ( p =0.046), and regional lymph node metastasis ( p =0.010) were significant risk factors for disease recurrence. Multivariate analysis identified regional lymph node metastasis as an independent prognostic factor for disease recurrence ( p =0.027), and lymphovascular invasion as an independent prognostic factor for overall survival ( p =0.033). Conclusions: The conservative surgical approach of partial parotidectomy can yield oncologic outcomes comparable to superficial or total parotidectomies under careful patient","PeriodicalId":10318,"journal":{"name":"Clinical and Experimental Otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Otorhinolaryngology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21053/ceo.2023.00014","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: This study aimed to compare the oncological outcomes of partial and superficial or total parotidectomies for superficial T1 or T2 primary parotid cancers and investigate their prognostic factors and recurrence patterns. Methods: The medical records of 77 patients with T1–2 primary parotid malignancies between May 2003 and March 2022 were retrospectively reviewed. Univariate and multivariate analyses were performed to evaluate the prognostic factors associated with overall survival, disease-free survival, and local and distant recurrences. Results: The average follow-up duration was 70.2 months (range,12–202 months). The 5-year overall and disease-free survival rates were 88.7% and 77.1%, respectively. Twenty-two patients underwent partial parotidectomy, and 55 underwent superficial or total parotidectomy. There were no significant differences in the disease recurrence ( p =0.320) and mortality rates ( p =0.884) of the partial and superficial or total parotidectomy groups. The mean duration of surgery was shorter and the overall complication rates were significantly lower for the partial group than for the superficial or total parotidectomy group ( p =0.049). Sixteen cases of recurrence occurred during the study period (20.8%). Univariate analyses showed that high-grade tumors ( p =0.006), lymphovascular invasion ( p =0.046), and regional lymph node metastasis ( p =0.010) were significant risk factors for disease recurrence. Multivariate analysis identified regional lymph node metastasis as an independent prognostic factor for disease recurrence ( p =0.027), and lymphovascular invasion as an independent prognostic factor for overall survival ( p =0.033). Conclusions: The conservative surgical approach of partial parotidectomy can yield oncologic outcomes comparable to superficial or total parotidectomies under careful patient
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
浅表 T1-2 原发性腮腺癌部分切除术与浅表或全腮腺切除术的比较
研究目的本研究旨在比较浅表 T1 或 T2 原发性腮腺癌部分切除术和浅表或全腮腺切除术的肿瘤学疗效,并探讨其预后因素和复发模式。方法回顾性分析2003年5月至2022年3月期间77例T1-2原发性腮腺恶性肿瘤患者的病历。进行单变量和多变量分析,评估与总生存期、无病生存期、局部和远处复发相关的预后因素。结果显示平均随访时间为70.2个月(12-202个月)。5年总生存率和无病生存率分别为88.7%和77.1%。22名患者接受了腮腺部分切除术,55名患者接受了腮腺表层或全部切除术。腮腺部分切除术组与腮腺表层或全部切除术组的疾病复发率(P =0.320)和死亡率(P =0.884)无明显差异。腮腺部分切除术组的平均手术时间较短,总体并发症发生率明显低于腮腺表层或全部切除术组(P =0.049)。研究期间有16例复发(20.8%)。单变量分析显示,高级别肿瘤(P =0.006)、淋巴管侵犯(P =0.046)和区域淋巴结转移(P =0.010)是疾病复发的重要风险因素。多变量分析发现,区域淋巴结转移是疾病复发的独立预后因素(p =0.027),淋巴管侵犯是总生存期的独立预后因素(p =0.033)。结论腮腺部分切除术这种保守的手术方法在仔细观察病人的情况下,可以获得与浅表或全部腮腺切除术相当的肿瘤治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.90
自引率
6.70%
发文量
49
审稿时长
6-12 weeks
期刊介绍: Clinical and Experimental Otorhinolaryngology (Clin Exp Otorhinolaryngol, CEO) is an international peer-reviewed journal on recent developments in diagnosis and treatment of otorhinolaryngology-head and neck surgery and dedicated to the advancement of patient care in ear, nose, throat, head, and neck disorders. This journal publishes original articles relating to both clinical and basic researches, reviews, and clinical trials, encompassing the whole topics of otorhinolaryngology-head and neck surgery. CEO was first issued in 2008 and this journal is published in English four times (the last day of February, May, August, and November) per year by the Korean Society of Otorhinolaryngology-Head and Neck Surgery. The Journal aims at publishing evidence-based, scientifically written articles from different disciplines of otorhinolaryngology field. The readership contains clinical/basic research into current practice in otorhinolaryngology, audiology, speech pathology, head and neck oncology, plastic and reconstructive surgery. The readers are otolaryngologists, head and neck surgeons and oncologists, audiologists, and speech pathologists.
期刊最新文献
Video Head Impulse Test Coherence Predicts Vertigo Recovery in Sudden Sensorineural Hearing Loss with Vertigo. Long-term Assessment of Speech and Swallowing Function in Laryngopharyngeal Cancer Patients After J-Flap Reconstruction. Clinical significance of gross extrathyroidal extension to only the strap muscle according to tumor size in differentiated thyroid cancer: a systematic review and metaanalysis. Consensus Statement: Postoperative Management after Balloon Dilation of the Eustachian Tube. Therapeutic Effectiveness SNOT 22-based interdose interval adjustment of dupilumab for CRSwNP.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1